sucraid market analysis, sucraid market trends, sucraid market growth, sucraid market share, sucraid market key players, sucraid market size
What is the current size and annual growth rate of the sucraid market?
The sucraid market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to government support, clinical evidence, increased diagnosis of CSID, patient advocacy group and lack of alternatives
The sucraidmarket size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to telemedicine growth, supportive patient assistance programs, collaborations and partnerships, policy changes favoring rare diseases and focused clinical trials. Major trends in the forecast period include growth in recombinant enzyme production, advancements in oral biologic, expansion of synthetic biology, gene therapy integration, and development of biobetters.
Get Your Free Sample of The Global Sucraid Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20410&type=smp
Which major factors have contributed to the expansion of the sucraid market?
The increase in rare genetic disorders is expected to propel the growth of the sucraid market going forward. Rare genetic disorders refer to conditions caused by mutations or changes in an individual’s DNA and occur infrequently in the general population. The prevalence of genetic disorders can be due to advancements in genetic testing leading to better detection, environmental influences, and, in some cases, lifestyle factors that contribute to mutations in DNA. Sucraid provides essential enzyme replacement therapy for individuals with the rare genetic disorder congenital sucrase-isomaltase deficiency (CSID), enabling them to properly digest sucrose and maltose, which are otherwise indigestible due to a deficiency or absence of the sucrase-isomaltase enzyme. For instance, in September 2023, according to a report published by the Cystic Fibrosis Trust, a UK-based national charity, in the UK, the number of people registered with cystic fibrosis (a genetic disorder) surpassed 11,000 in 2022, an increase of 5% compared to the previous year. Therefore, the increase in rare genetic disorders drives growth in the sucraid market.
How is the sucraid market segmented?
The sucraid market covered in this report is segmented –
1) By Clinical Indication: Congenital Sucrase-Isomaltase Deficiency (CSID); Chronic Diarrhea Associated With CSID; Unexplained Gastrointestinal Symptoms (Suspected CSID)
2) By Distribution Channel: Hospitals; Pharmacies
3) By End User: Pediatric; Adult
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/sucraid-global-market-report
Who are the top competitors in the sucraid market?
Major companies operating in the sucraid market are QOL Medical LLC
Which key trends are expected to influence the sucraid market in the coming years?
The key trend in the sucraid market is obtaining regulatory approvals for new formulations and manufacturing processes, which enhances product availability and patient access. Regulatory approvals refer to the formal authorization granted by governmental or regulatory bodies for a drug, medical device, or treatment to be marketed and used by the public. For instance, in September 2023, QOL Medical LLC., a US-based pharmaceutical company, received Food and Drug Administration (FDA) approval for Sucraid (sacrosidase) in single-use containers, which is specifically designed for patients over 33 pounds (15 kg). This approval addresses previous supply shortages and improves patient access by providing a more convenient dosage form that maintains stability at room temperature for up to three days. The focus on regulatory compliance facilitates the restoration of Sucraid’s supply and highlights the importance of innovation in treatment delivery for rare diseases.
Which regional trends are influencing the sucraid market, and which area dominates the industry?
North America was the largest region in the sucraid market in 2024. The regions covered in the sucraid market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Sucraid Market Report 2025 Offer?
The sucraid market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Sucraid is a prescription medication that contains the active ingredient sacrosidase, an enzyme that helps break down sucrose (table sugar) into glucose and fructose. It is used primarily for managing congenital sucrase-isomaltase deficiency (CSID), a rare genetic disorder where the body cannot properly digest sucrose and certain other sugars.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20410
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
